JPMorgan Chase & Co’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $708K | Buy |
47,279
+5,723
| +14% | +$85.7K | ﹤0.01% | 3907 |
|
|
2025
Q1 | $671K | Buy |
41,556
+6,308
| +18% | +$102K | ﹤0.01% | 3860 |
|
|
2024
Q4 | $821K | Buy |
35,248
+5,775
| +20% | +$134K | ﹤0.01% | 3908 |
|
|
2024
Q3 | $867K | Buy |
29,473
+6,701
| +29% | +$197K | ﹤0.01% | 3719 |
|
|
2024
Q2 | $535K | Buy |
22,772
+22,761
| +206,918% | +$535K | ﹤0.01% | 3829 |
|
|
2024
Q1 | $417 | Sell |
11
-30
| -73% | -$1.14K | ﹤0.01% | 5729 |
|
|
2023
Q4 | $882 | Hold |
41
| – | – | ﹤0.01% | 5813 |
|
|
2023
Q3 | $502 | Sell |
41
-2
| -5% | -$24 | ﹤0.01% | 5768 |
|
|
2023
Q2 | $481 | Hold |
43
| – | – | ﹤0.01% | 5644 |
|
|
2023
Q1 | $0 | Hold |
43
| – | – | ﹤0.01% | 6109 |
|
|
2022
Q4 | $0 | Sell |
43
-103
| -71% | – | ﹤0.01% | 5917 |
|
|
2022
Q3 | $2K | Buy |
146
+53
| +57% | +$726 | ﹤0.01% | 5348 |
|
|
2022
Q2 | $1K | Sell |
93
-904
| -91% | -$9.72K | ﹤0.01% | 5510 |
|
|
2022
Q1 | $58K | Buy |
997
+162
| +19% | +$9.42K | ﹤0.01% | 4961 |
|
|
2021
Q4 | $99K | Buy |
835
+68
| +9% | +$8.06K | ﹤0.01% | 4834 |
|
|
2021
Q3 | $152K | Sell |
767
-2,738
| -78% | -$543K | ﹤0.01% | 4532 |
|
|
2021
Q2 | $610K | Buy |
3,505
+2,345
| +202% | +$408K | ﹤0.01% | 3885 |
|
|
2021
Q1 | $230K | Sell |
1,160
-24
| -2% | -$4.76K | ﹤0.01% | 4400 |
|
|
2020
Q4 | $233K | Buy |
1,184
+558
| +89% | +$110K | ﹤0.01% | 4102 |
|
|
2020
Q3 | $111K | Buy |
626
+61
| +11% | +$10.8K | ﹤0.01% | 4000 |
|
|
2020
Q2 | $131K | Sell |
565
-743
| -57% | -$172K | ﹤0.01% | 3852 |
|
|
2020
Q1 | $152K | Sell |
1,308
-630
| -33% | -$73.2K | ﹤0.01% | 3809 |
|
|
2019
Q4 | $371K | Sell |
1,938
-256
| -12% | -$49K | ﹤0.01% | 3557 |
|
|
2019
Q3 | $422K | Buy |
2,194
+56
| +3% | +$10.8K | ﹤0.01% | 3409 |
|
|
2019
Q2 | $343K | Buy |
2,138
+1,871
| +701% | +$300K | ﹤0.01% | 3533 |
|
|
2019
Q1 | $53K | Buy |
267
+99
| +59% | +$19.7K | ﹤0.01% | 4214 |
|
|
2018
Q4 | $32K | Sell |
168
-1,660
| -91% | -$316K | ﹤0.01% | 4404 |
|
|
2018
Q3 | $437K | Sell |
1,828
-2,973
| -62% | -$711K | ﹤0.01% | 3544 |
|
|
2018
Q2 | $1.27M | Buy |
4,801
+2,775
| +137% | +$734K | ﹤0.01% | 3026 |
|
|
2018
Q1 | $502K | Buy |
2,026
+1,784
| +737% | +$442K | ﹤0.01% | 3374 |
|
|
2017
Q4 | $33K | Buy |
242
+234
| +2,925% | +$31.9K | ﹤0.01% | 4263 |
|
|
2017
Q3 | $1K | Sell |
8
-43
| -84% | -$5.38K | ﹤0.01% | 4244 |
|
|
2017
Q2 | $5K | Buy |
+51
| New | +$5K | ﹤0.01% | 4146 |
|